Old Web
English
Sign In
Acemap
>
authorDetail
>
Michelle M. Zhang
Michelle M. Zhang
Fred Hutchinson Cancer Research Center
Immunology
Medicine
Etoposide
Tositumomab
Transplant Conditioning
3
Papers
61
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
2013
British Journal of Haematology
Lihua E. Budde
Michelle M. Zhang
Andrei R. Shustov
John M. Pagel
Ted Gooley
George R. Oliveira
Tara L. Chen
Nancy L. Knudsen
Jennifer E. Roden
Britt Kammerer
Shani L. Frayo
Thomas A. Warr
Thomas E. Boyd
Oliver W. Press
Ajay K. Gopal
Show All
Source
Cite
Save
Citations (30)
A Phase I Study of Vorinostat (V) in Combination with Rituximab (R), Ifosphamide, Carboplatin, and Etoposide (ICE) for Patients with Relapsed or Refractory Lymphoid Malignancies or Untreated T- or Mantle Cell Lymphoma.
2009
Blood
Lihua E. Budde
Michelle M. Zhang
Andrei R. Shustov
John M. Pagel
Thomas A. Warr
Tara L. Chen
George R. Oliveira
Ted Gooley
Ajay K. Gopal
Show All
Source
Cite
Save
Citations (4)
Radioimmunotherapy based conditioning regimens for stem cell transplantation
2008
Seminars in Hematology
Michelle M. Zhang
Ajay K. Gopal
Show All
Source
Cite
Save
Citations (27)
1